Related Experiment Videos
Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications
Fredrik Bäckhed1, Staffan Normark, Elke K H Schweda
1Microbiology and Tumorbiology Center, Karolinska Institutet, 17177 Stockholm, Sweden. fackhed@molecool.wustl.edu
Microbes and Infection
|October 14, 2003
Summary
Epithelial cells detect bacteria using lipopolysaccharide (LPS). The O-antigen part of LPS interferes with CD14-Toll-like receptor (TLR)-4 recognition, modulating inflammatory responses.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Epithelial cells are the first line of defense against invading bacteria.
- Lipopolysaccharide (LPS) is a key bacterial component recognized by epithelial cells via the CD14-Toll-like receptor (TLR)-4 complex.
Purpose of the Study:
- To identify the specific substructures of LPS recognized by the TLR4 receptor complex.
- To investigate the role of LPS substructures in modulating inflammatory responses.
Main Methods:
- Genetic modification of Escherichia coli to express penta-acylated lipid A.
- Assessing the immunogenicity and pro-inflammatory signaling of modified LPS.
- Evaluating the antagonistic effects of penta-acylated LPS on hexa-acylated LPS-induced IL-8 production.
Main Results:
- The O-antigen of LPS does not mediate inflammatory response but interferes with lipid A recognition.
- Penta-acylated lipid A from E. coli showed reduced immunogenicity and inhibited pro-inflammatory signaling.
- Penta-acylated LPS from Pseudomonas aeruginosa acted as an antagonist to hexa-acylated E. coli LPS.
Conclusions:
- LPS substructure composition significantly impacts TLR4-mediated inflammatory signaling.
- Hypo-acylated lipid A, found in gut microflora and chronic infection bacteria, can act as an antagonist.
- Microflora composition may play a crucial role in modulating epithelial cell inflammatory responses.